News
Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense
22 Apr 24
Biotech, News, Health Care, Contracts, General
Plus Therapeutics Announces Validation & Clinical Implementation Of CSF-01 Leptomeningeal Cancer Cell Diagnostic
25 Mar 24
Biotech, News, General
Recap: Plus Therapeutics Q4 Earnings
5 Mar 24
Earnings
Plus Therapeutics Q4 EPS $(0.70) Beats $(1.07) Estimate, Sales $1.31M Beat $1.06M Estimate
5 Mar 24
Earnings, Earnings Beats, News
Earnings Scheduled For March 5, 2024
5 Mar 24
Earnings
Plus Therapeutics Earnings Preview
4 Mar 24
Earnings
Press releases
Plus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell Diagnostic
25 Mar 24
Press Releases
Plus Therapeutics Completes Dosing in Cohort 5 of ReSPECT-LM Phase 1 Trial of Rhenium (186Re) Obisbemeda in Leptomeningeal Metastases
11 Mar 24
Press Releases
Plus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
5 Mar 24
Earnings, Press Releases